An increasing number of newly-approved drugs by the US Food and Drug Administration (FDA) have been associated with expedited development or review programs, though many of these approved drugs are ...
BioPharma Dive: Terremoto raises $108M to pursue development of drugs targeting AKT
Radiopharmaceuticals are rapidly becoming one of the most dynamic areas of oncology drug development. By combining molecular targeting with controlled radiation delivery, these therapies introduce a ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
TMCnet: Lantern Pharma Launches withZeta.ai - the World's First Multi-Agentic A.I. Co-Scientist for Rare Cancer Drug Discovery & Development - Subscriptions Now Open; Debut Events at ...
PM Eastern, Lantern Pharma will host an exclusive live demonstration of withZeta.ai at Nasdaq MarketSite in New York City - one of the world's most recognized venues for presenting innovation to the ...
Lantern Pharma Launches withZeta.ai - the World's First Multi-Agentic A.I. Co-Scientist for Rare Cancer Drug Discovery & Development - Subscriptions Now Open; Debut Events at ...
University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery that could dramatically accelerate the creation of new medicines. UVA's ...